Latest Breaking News On - லாரன் ஜே ம்க்கார்தீ - Page 1 : comparemela.com

FDA Approves Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose News provided by Share this article Share this article SILVER SPRING, Md., April 30, 2021 /PRNewswire/ The U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose. The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity. The FDA had previously approved 2 mg and 4 mg naloxone nasal spray products. Naloxone is a medicine that can be administered by individuals with or without medical training to help reduce opioid overdose deaths. If naloxone is administered quickly, it can counter the opioid overdose effects, usually within minutes. A higher dose of naloxone provides an additional option in the treatment of opioid overdoses.  

Lauren-jei-mccarthy
Patrizia-cavazzoni
Drug-administration
Hikma-pharmaceuticals
Drug-evaluation
Federal-food
லாரன்-ஜே-ம்க்கார்தீ
ஹிக்மா-மருந்துகள்
மருந்து-மதிப்பீடு
கூட்டாட்சியின்-உணவு